Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Biologic License Application (BLA): 022575
Company: SHIRE HUMAN GENETIC

• This Former NDA Was Deemed To Be a BLA on March 23, 2020.

Products on BLA 22575

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
VPRIV	VELAGLUCERASE ALFA	400 UNITS/VIAL	INJECTABLE;INTRAVENOUS	Prescription	None	No	No
VPRIV	VELAGLUCERASE ALFA	200 UNITS/VIAL	POWDER;INTRAVENOUS	Discontinued	None	No	No

Labels for BLA 022575

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
07/10/2024	SUPPL-30	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022575s030lbl.pdf
12/10/2020	SUPPL-26	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022575s026lbl.pdf
11/06/2019	SUPPL-23	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022575s023lbl.pdf
07/30/2019	SUPPL-22	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022575s022lbl.pdf
05/05/2015	SUPPL-17	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022575s017lbl.pdf
11/21/2013	SUPPL-12	Efficacy-Labeling Change With Clinical Data	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022575s012lbl.pdf
10/02/2013	SUPPL-13	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022575s013lbl.pdf
03/26/2013	SUPPL-9	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022575s007s009lbl.pdf
03/26/2013	SUPPL-7	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022575s007s009lbl.pdf
02/26/2010	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022575lbl.pdf